A Medical Device Daily

Genetix (New Milton, UK) reported that it has acquired data management software company SlidePath (Dublin, Ireland) for cash and shares worth up to €3.7 million. Genetix said it believes that SlidePath's expertise in analysis and data management software complements its' existing strengths and accelerates the company's position in the growing digital pathology market.

Digital pathology is the management and interpretation of high-resolution images taken of tissue samples. These samples are mounted onto glass slides, scanned, converted into digital images to create an electronic record of each specimen. Digitized slides can then be managed and viewed online, enabling pathologists to analyze and share sample images between sites and to examine them remotely.

"We're delighted to be joining the Genetix Group," said Donal O'Shea, CEO of SlidePath. "The combination of skills and technologies offered by Genetix and SlidePath will provide tools with the accuracy, speed and cost-effectiveness necessary to drive growth in the digital pathology market."

Genetix provides imaging and intelligent image analysis in the life science and diagnostic markets.

In other dealmaking news:

• MEDecision (Wayne, Pennsylvania) said it has finalized its acquisition of HxTechnologies (HxTI; Philadelphia), a health information exchange (HIE) company that specializes in enabling the seamless and secure flow of clinical data among health care stakeholders.

The deal allows MEDecision to embed HxTI's HIE technologies, particularly the iHistory HIE platform, into its Alineo collaborative health care management platform and Nexalign advanced health information exchange service. MEDecision will use iHistory intelligence to augment Alineo's analytics capabilities, enabling more precise patient identification, gaps in care recognition, and clinical summary and treatment plan development. The company says that iHistory will expand Nexalign's ability to assemble and deliver actionable, real-time clinical information – including diagnostic-quality medical images – and simplify its interoperability with other systems.

• Mednax (Fort Lauderdale, Florida) has completed the acquisition of a physician group practice that provides neonatal intensive care and well-baby care at five hospitals throughout the Houston metropolitan area.

Houston Neonatal-Perinatal Physicians is a 12-physician practice that provides care at three hospitals with Level III neonatal intensive care units, and two hospitals with Level II units.

The group, which has more than 25 years of continuous patient care in the Houston community, will provide services as part of Pediatrix Medical Group, Mednax's operating unit focused on neonatal, maternal-fetal, pediatric subspecialty and newborn hearing screens.

Mednax is a medical group comprised of neonatal, maternal-fetal and pediatric physician subspecialty services as well as anesthesia services.